The meeting was attended by leaders including Cai Haishan, Chairman of the Board of Directors of Federal Pharmaceuticals; Wang Peng, General Manager of Human Resources and Legal Affairs of the Group; Liu Hongchi, General Manager of Federal Animal Protection Business Unit; Wang Yazheng, General Manager of Federal Animal Protection China Marketing Center; and pet dealers from all over the country.

◎ Cai Haishan, Chairman of the Board of Directors of Federal Pharmaceuticals

At the beginning of the press conference, Chairman Cai Haishan delivered a speech. He emphasized that Federal Animal Health, relying on the group's more than 30 years of experience in human drug research and development and pharmaceutical manufacturing, adheres to the philosophy of "taking research and development as the core and quality as life," and is committed to breaking through low-level competition and becoming a high-value pioneer. The seven new products launched this time reflect the company's strategic determination. In the future, the company will build a complete product system covering prevention, treatment, nutrition to care, and build a "community of shared future" with its partners to jointly usher in a new era of pet health.

◎Liu Hongchi, General Manager of Federal Animal Protection Division

General Manager Liu Hongchi shared his insights on the theme of "Innovation-Driven, Breaking Through and Establishing a New Order." Facing the critical transition of the Chinese pet industry from "quantitative expansion" to "steady growth driven by quality and structural optimization," the company proposed the "Golden Triangle Strategic Model." This model involves providing solutions covering the entire lifecycle of pets—prevention, treatment, care, and maintenance—along with a continuously iterating product pipeline (over 30 products in development) and sales promotion support. Together with industry partners, the company aims to address market challenges, continuously promote high-quality development in the pet healthcare field, and strive to build a global animal health ecosystem.

◎New Product Launch Ceremony

◎Wang Yazheng, General Manager of Federal Animal Protection China Marketing Center

General Manager Wang Yazheng explains the ordering policy for the new product pre-sale event.

◎Nie Xinlei, Federal Animal Protection Pet Expansion Technology Department

Federal Animal Protection ownsCefavirenz sodiumOur end-to-end quality control system ensures that the entire production process, from raw materials (APIs) to finished products, is controllable, guaranteeing the accuracy and purity of each batch of products. This eliminates quality risks at the source and provides more efficient, safer, and longer-lasting anti-infection solutions for veterinary clinics.

◎Lianchongxing Kit: Cefotaxime for Injection, Special Diluent

In addition to cefavirenz sodium, the company has also launched a range of products covering chronic disease management, skin health, nutritional support, and environmental disinfection, aiming to provide companion animals with comprehensive and precise health solutions.Including the following four core products:Bangchongping”、“Lianguanidin”、“Bang Shi Le”、“Bangfujing”。

◎Bangchongping, Bangshile, Bangfujing, Lianguanjing

◎Federal Animal Protection Pet Expansion Technology Department - Ye Fan

The company's strategic move into pet health products stems from the increasing trend of pets "aging" and the large number of chronic diseases requiring long-term management in clinical practice, such as the prevalent urinary system and liver problems. Traditional treatment methods have pain points in terms of pet owner compliance, convenience of long-term medication, and prevention of relapse.

Therefore, the company is committed to extending from "passive treatment" to "active prevention and assisted rehabilitation," launching a variety of scientifically formulated medical supplement products to build an integrated health solution encompassing "treatment + nutrition + health care." This includes the newly launched product…Minotong Urinary Tablets"and"Ganorin Liver Protection Tablets”。

◎Ganolin Liver Protection Tablets (for dogs/cats), Minotong Urinary Tablets

◎Awards Ceremony

◎Glimpses of the Meeting

◎A visit to the factory areas of Zhuhai Federal Animal Health Co., Ltd. and Zhuhai Federal Biomedical Co., Ltd.

With the launch of seven new products, a new chapter for Federal Animal Health begins. This simultaneous release of seven products demonstrates the strength of the company's robust product pipeline and provides veterinarians and pet owners with more diverse product choices. Moving forward, the company will continue to uphold the quality of human-grade medicine, remain committed to its partners, and inject continuous "Federal Power" into the sustainable development of China's pet health industry through constantly iterating innovative products and a sound market strategy.

◎Group photo

[Manuscript] Federal Animal Protection Division

[Photography] Zhuhai Federal Animal Protection

[Edited by] Federal Animal Protection Division, Group Brand and Culture Department

[Reviewed by] Group Brand Culture Department, Federal Animal Protection, Group Legal Center